Drug comparisons
Eptinezumab vs Atogepant
Eptinezumab (Vyepti) vs Atogepant (Qulipta) for migraine: Both CGRP-targeted. Eptinezumab is IV, Atogepant is oral. Similar efficacy; choose injection or tablet.
No comparison dimensions are available for this page.
Clinical context
Patients comparing CGRP monoclonal antibodies and receptor antagonists for chronic or episodic migraine prevention.
Bottom line
Both Eptinezumab and Atogepant are effective options for migraine prevention by targeting CGRP, with the choice depending on whether an injectable or oral medication is preferred.
All medication comparisons